Paper8137461
Preclinical toxicology and tissue platinum distribution of novel oral antitumour platinum complexes: ammine/amine platinum(IV) dicarboxylates.
McKeage MJ and 5 others. Cancer Chemother Pharmacol, 1994. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Preclinical toxicology and tissue platinum distribution of novel oral antitumour platinum complexes: ammine/amine platinum(IV) dicarboxylates. Papers, record 8137461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8137461
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Preclinical toxicology and tissue platinum distribution of novel oral antitumour platinum complexes: ammine/amine platinum(IV) dicarboxylates.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Organoplatinum Compounds | Major topic |
| Administration, Oral | |
| Animals | |
| Carboplatin | |
| Cisplatin | |
| Time Factors | |
| Tissue Distribution |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8494733 | Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodents. | Br J Cancer | 1993 | https://conductscience.org/library/papers/8494733 | PubMed |
| 2 | 8388318 | Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug. | Cancer Res | 1993 | https://conductscience.org/library/papers/8388318 | PubMed |
| 3 | 1737343 | Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines. | Cancer Res | 1992 | https://conductscience.org/library/papers/1737343 | PubMed |
| 4 | 1921314 | Why modification of the LD50 test will not be enough. | Lab Anim | 1991 | https://conductscience.org/library/papers/1921314 | PubMed |
| 5 | 3277732 | Comparative distribution and excretion of carboplatin and cisplatin in mice. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3277732 | PubMed |
| 6 | 3555590 | Haematological toxicity of carboplatin in rats. | Br J Cancer | 1987 | https://conductscience.org/library/papers/3555590 | PubMed |
| 7 | 21573668 | Antitumor-activity of orally-administered ammine amine platinum (iv) dicarboxylate complexes against a panel of human ovarian-carcinoma xenografts. | Int J Oncol | 1993 | https://conductscience.org/library/papers/21573668 | PubMed |
| 8 | 3039867 | Flameless atomic absorption spectrophotometric determination of platinum in tissues solubilized in hyamine hydroxide. | Anal Biochem | 1987 | https://conductscience.org/library/papers/3039867 | PubMed |
| 9 | 3085925 | Protective effect of sodium-2-mercaptoethanesulfonate on the gastrointestinal toxicity and lethality of cis-diamminedichloroplatinum. | Cancer Res | 1986 | https://conductscience.org/library/papers/3085925 | PubMed |
| 10 | 1688349 | Animal testing. Tide turns against LD50. | Nature | 1991 | https://conductscience.org/library/papers/1688349 | PubMed |
| 11 | 5636962 | Assay of intestinal disaccharidases. | Anal Biochem | 1968 | https://conductscience.org/library/papers/5636962 | PubMed |
| 13 | 445419 | Adequacies and inadequacies in assessing murine toxicity data with antineoplastic agents. | Cancer Res | 1979 | https://conductscience.org/library/papers/445419 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40650048 | "Non-Classical" Platinum Complexes: A Concise Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40650048 | PubMed |
| 10711843 | New oral chemotherapeutic agents for lung cancer. | Drugs | 1999 | https://conductscience.org/library/papers/10711843 | PubMed |
| 9820175 | Potent and non-specific inhibition of cytochrome P450 by JM216, a new oral platinum agent. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9820175 | PubMed |
| 8573296 | Comparative adverse effect profiles of platinum drugs. | Drug Saf | 1995 | https://conductscience.org/library/papers/8573296 | PubMed |
| 7987975 | Kinetics of tissue disposition of cis-ammine/cyclohexylamine-dichloroplatinum(II) and cisplatin in mice bearing FSaIIC tumors. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/7987975 | PubMed |
| 7981487 | New platinum agents. A comparison in ovarian cancer. | Drugs Aging | 1994 | https://conductscience.org/library/papers/7981487 | PubMed |
| 7554035 | A phase I and pharmacology study of an oral platinum complex, JM216: dose-dependent pharmacokinetics with single-dose administration. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7554035 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8137461
GET https://conductscience.org/api/papers/v1/8137461/authors